Search Results - "Pfeiler, D"

Development of a zero-energy-sauna: Simulation study of thermal energy storage by Schaefer, M., Raab, A., Gerle, M., Pfeiler, D., Vogel, J., Thess, André

“…•Presentation of innovative Zero-Energy-Sauna concept which solar energy and thermal energy storage.•Development and investigation of numerical models for two…”
Get full text

Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin by Gil-Parrado, Shirley, Assfalg-Machleidt, Irmgard, Fiorino, Ferdinando, Deluca, Dominga, Pfeiler, Dietmar, Schaschke, Norbert, Moroder, Luis, Machleidt, Werner

“…The ubiquitous calpains, mu- and m-calpain, have been implicated in essential physiological processes and various pathologies. Cell-permeable specific…”
Get more information

Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain by Díaz, B G, Gross, S, Assfalg-Machleidt, I, Pfeiler, D, Gollmitzer, N, Gabrijelcic-Geiger, D, Stubbs, M T, Fritz, H, Auerswald, E A, Machleidt, W

“…Within the cystatin superfamily, only kininogen domain 2 (KD2) is able to inhibit mu- and m-calpain. In an attempt to elucidate the structural requirements of…”
Get more information

Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain by Fernández-Montalván, Amaury, Assfalg-Machleidt, Irmgard, Pfeiler, Dietmar, Fritz, Hans, Jochum, Marianne, Machleidt, Werner

“…The ubiquitous mu- and m-calpains are Ca2+-dependent cysteine proteases. They are activated via rearrangement of the catalytic domain II induced by cooperative…”
Get full text

Processing of artificial peptide-DNA-conjugates by the mitochondrial intermediate peptidase (MIP) by Seibel, M, Bachmann, C, Schmiedel, J, Wilken, N, Wilde, F, Reichmann, H, Isaya, G, Seibel, P, Pfeiler, D

“…Import of DNA from the cytoplasm into the mitochondrial matrix is an obligatory step for an in organello site-directed mutagenesis or gene therapy approach on…”
Get more information

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial by Gnant, Michael, Prof, Pfeiler, Georg, MD, Dubsky, Peter C, MD, Hubalek, Michael, MD, Greil, Richard, Prof, Jakesz, Raimund, Prof, Wette, Viktor, MD, Balic, Marija, MD, Haslbauer, Ferdinand, MD, Melbinger, Elisabeth, MD, Bjelic-Radisic, Vesna, MD, Artner-Matuschek, Silvia, MD, Fitzal, Florian, MD, Marth, Christian, Prof, Sevelda, Paul, MD, Mlineritsch, Brigitte, MD, Steger, Günther G, MD, Manfreda, Diether, MD, Exner, Ruth, MD, Egle, Daniel, MD, Bergh, Jonas, Prof, Kainberger, Franz, MD, Talbot, Susan, MSc, Warner, Douglas, MD, Fesl, Christian, PhD, Singer, Christian F, Prof

“…Summary Background Adjuvant endocrine therapy compromises bone health in patients with breast cancer, causing osteopenia, osteoporosis, and fractures…”
Get full text

The cheletropic trapping of nitric oxide by the bis-ketene 1,2-dicarbonylcyclohexa-3,5-diene and the diene 3,4-diphenyl-2,5-dimethyl-2,4-hexadiene by Adam, Waldemar, Bottle, Steven E., Darren Grice, I., Pfeiler, Dietmar, Wentrup, Curt

“…We report the first example of the cheletropic trapping of nitric oxide with a bis-ketene. In the presence of nitric oxide the bis-ketene…”
Get full text

Reaction of substituted anthracenes and a butadiene with nitric oxide: product formation determined by EPR spectroscopy by Pfeiler, D, Grice, I D, Bottle, S E, Hanson, G R

“…When nitric oxide (NO), generated from nitric acid and copper, was reacted with a series of 9,10-substituted anthracenes, only 9,10-dimethylanthracene gave EPR…”
Get more information

The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy by Farr, Alex, MD PhD, Stolz, Myriam, MD, Baumann, Lukas, BSc BSc, Bago-Horvath, Zsuzsanna, MD PhD, Oppolzer, Elisabeth, MD, Pfeiler, Georg, MD, Seifert, Michael, MD, Singer, Christian F., MD MPH

“…Abstract Purpose The effect of obesity in breast cancer patients undergoing neoadjuvant chemotherapy (NAC) remains controversial. The aim of this study was to…”
Get full text